Header cover image

Swedish (OMX) Healthcare Sector Analysis

UpdatedJun 06, 2025
DataAggregated Company Financials
Companies172
  • 7D5.7%
  • 3M5.4%
  • 1Y3.3%
  • YTD0.2%

Over the last 7 days, the Healthcare industry has risen 5.7%, driven by gains in Sectra and Camurus of 14% and 26%, respectively. In the same time, Elekta was down 5.6%. This means that the industry has gained 3.3% over the past year. Looking forward, earnings are forecast to grow by 29% annually.

Sector Valuation and Performance

Has the Swedish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 07 Jun 2025SEK 630.5bSEK 226.4bSEK 5.9b43.8x107.4x2.8x
Mon, 05 May 2025SEK 599.2bSEK 223.6bSEK 4.9b36.9x122x2.7x
Wed, 02 Apr 2025SEK 572.6bSEK 220.9bSEK 5.4b36x106x2.6x
Fri, 28 Feb 2025SEK 584.8bSEK 206.3bSEK 4.3b36.3x136.9x2.8x
Sun, 26 Jan 2025SEK 583.0bSEK 202.6b-SEK 2,675,705,168.5040.6x-217.9x2.9x
Tue, 24 Dec 2024SEK 577.7bSEK 202.7b-SEK 2,503,419,196.5238.4x-230.8x2.9x
Thu, 21 Nov 2024SEK 500.2bSEK 200.1b-SEK 2,729,298,500.7837.5x-183.3x2.5x
Sat, 19 Oct 2024SEK 599.2bSEK 198.9b-SEK 3,207,874,256.2939.4x-186.8x3x
Mon, 16 Sep 2024SEK 622.6bSEK 200.0b-SEK 2,795,377,192.9841.1x-222.7x3.1x
Wed, 14 Aug 2024SEK 575.2bSEK 199.5b-SEK 2,609,089,125.3641.6x-220.5x2.9x
Fri, 12 Jul 2024SEK 575.8bSEK 195.8b-SEK 3,174,026,561.3538.5x-181.4x2.9x
Sun, 09 Jun 2024SEK 564.1bSEK 195.9b-SEK 3,147,692,207.7736.4x-179.2x2.9x
Tue, 07 May 2024SEK 539.0bSEK 196.5b-SEK 3,171,941,416.9135.3x-169.9x2.7x
Thu, 04 Apr 2024SEK 522.4bSEK 192.9b-SEK 3,320,873,825.3045.5x-157.3x2.7x
Sat, 02 Mar 2024SEK 512.0bSEK 192.1b-SEK 3,765,632,828.3645.1x-136x2.7x
Mon, 29 Jan 2024SEK 550.9bSEK 191.7b-SEK 893,669,632.0049.4x-616.5x2.9x
Wed, 27 Dec 2023SEK 534.3bSEK 191.0b-SEK 960,561,471.0047.8x-556.3x2.8x
Fri, 24 Nov 2023SEK 502.0bSEK 190.1b-SEK 1,200,106,728.0051.1x-418.3x2.6x
Sun, 22 Oct 2023SEK 422.0bSEK 185.5b-SEK 1,926,276,118.0031.5x-219.1x2.3x
Tue, 19 Sep 2023SEK 446.9bSEK 185.7b-SEK 1,988,137,836.0036.1x-224.8x2.4x
Thu, 17 Aug 2023SEK 467.1bSEK 184.3b-SEK 1,028,799,667.0041.1x-454x2.5x
Sat, 15 Jul 2023SEK 465.5bSEK 179.6b-SEK 865,630,692.0044.4x-537.7x2.6x
Mon, 12 Jun 2023SEK 511.5bSEK 179.0b-SEK 714,102,762.0040.9x-716.3x2.9x
Wed, 10 May 2023SEK 520.9bSEK 176.7b-SEK 890,376,031.0041.8x-585x2.9x
Fri, 07 Apr 2023SEK 503.9bSEK 172.5b-SEK 1,445,623,661.0035.7x-348.6x2.9x
Sun, 05 Mar 2023SEK 495.0bSEK 171.8b-SEK 1,173,555,429.0038x-421.8x2.9x
Tue, 31 Jan 2023SEK 509.0bSEK 166.2bSEK 497.1m34.6x1024x3.1x
Thu, 29 Dec 2022SEK 464.2bSEK 165.6bSEK 699.0m31.5x664.1x2.8x
Sat, 26 Nov 2022SEK 491.2bSEK 164.8bSEK 767.7m30.8x639.8x3x
Mon, 24 Oct 2022SEK 456.1bSEK 161.1b-SEK 8,665,005.0029.6x-52638.2x2.8x
Wed, 21 Sep 2022SEK 438.6bSEK 159.5b-SEK 214,052,773.0029.9x-2049.2x2.7x
Fri, 19 Aug 2022SEK 531.8bSEK 157.0b-SEK 345,464,400.0030.8x-1539.4x3.4x
Sun, 17 Jul 2022SEK 511.1bSEK 154.6bSEK 251.6m28.8x2031.7x3.3x
Tue, 14 Jun 2022SEK 523.0bSEK 155.3bSEK 396.8m33.5x1318x3.4x
Price to Earnings Ratio

1318x


Total Market Cap: SEK 523.0bTotal Earnings: SEK 396.8mTotal Revenue: SEK 155.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Sector Price to Earnings3Y Average -786.4x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 107x which is higher than its 3-year average PE of -785x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 147% per year over the last three years.
  • Revenues for these companies have grown 13% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare sector?

SE Market0.90%
Healthcare5.74%
Pharma18.95%
Healthtech13.30%
Biotech5.15%
Life Sciences2.60%
Medical Equipment2.27%
Healthcare Services1.62%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 89.1x.
    • Analysts are expecting annual earnings growth of 33.6%, which is higher than its past year's earnings decline of 0.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 49% over the next 5 years.
  • This is better than its past earnings growth rate of 26% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 22% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SECT B SectraSEK 354.8014.2%
+SEK 8.5b
56.0%PE115.7x
CAMX CamurusSEK 638.5026.4%
+SEK 7.8b
8.2%PE68.4x
SOBI Swedish Orphan BiovitrumSEK 307.204.6%
+SEK 4.7b
6.4%PE26.6x
ASKER Asker Healthcare GroupSEK 106.606.6%
+SEK 2.5b
n/aPE106.9x
BIOA B BioArcticSEK 201.2014.7%
+SEK 2.3b
-16.2%PE19.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SOBI

SEK 307.20

Swedish Orphan Biovitrum

7D

4.6%

1Y

6.4%

SECT B

SEK 354.80

Sectra

7D

14.2%

1Y

56.0%

CAMX

SEK 638.50

Camurus

7D

26.4%

1Y

8.2%

EKTA B

SEK 49.96

Elekta

7D

-5.6%

1Y

-28.1%

BIOA B

SEK 201.20

BioArctic

7D

14.7%

1Y

-16.2%

CURAS

DKK 2.31

Curasight

7D

-37.4%

1Y

-79.0%

RAY B

SEK 329.00

RaySearch Laboratories

7D

8.6%

1Y

127.5%

GENO

SEK 25.55

Genovis AB (publ.)

7D

-5.2%

1Y

-29.9%

ACTI

SEK 0.21

Active Biotech

7D

-23.6%

1Y

-62.9%

ASKER

SEK 106.60

Asker Healthcare Group

7D

6.6%

1Y

n/a

GETI B

SEK 189.65

Getinge

7D

1.8%

1Y

1.6%

ONCO

SEK 1.52

Oncopeptides

7D

-14.0%

1Y

-55.7%

EQL

SEK 80.70

EQL Pharma

7D

-4.0%

1Y

50.6%

CANTA

SEK 1.16

Cantargia

7D

-21.0%

1Y

-74.1%

ALIF B

SEK 191.80

AddLife

7D

4.6%

1Y

61.9%